Ruminant BioTech, an innovative startup from New Zealand, is making strides to reduce methane emissions from livestock. With a newly launched research program valued at CAD$7.6 million (approximately $5.6 million), the company aims to validate its groundbreaking technology in Canada. This initiative will serve as a platform for global expansion, with particular focus on beef cattle.
A Three-Year Commitment
The ambitious three-year project seeks to secure regulatory approval and commercialize Ruminant BioTech’s methane reduction technology in Canada. This effort is bolstered by a CAD$2.8 million ($2.1 million) grant from the Alberta government, alongside co-funding commitments from two industry partners, totaling CAD$3.4 million ($2.5 million). Additionally, Ruminant BioTech is contributing CAD$1.4 million ($1 million) from its own resources.
The data generated from this program will not only support the company’s launch in Canada but will also pave the way for future expansion into major markets such as the United States, Brazil, and the European Union.
Establishing a North American Base
To oversee this pivotal project, Ruminant BioTech plans to establish its North American headquarters in Calgary. Collaborating with local colleges, universities, and federal research facilities, the program is set to kick off in August. This strategic move reflects the company’s commitment to integrating into the Canadian agricultural landscape.
Innovative Solution for Pasture-Raised Cattle
Ruminant BioTech’s approach to methane reduction is particularly noteworthy. While many companies have introduced feed additives aimed at lowering methane emissions, these often fall short for pasture-raised cattle, where regulated feeding is challenging. Instead, Ruminant BioTech employs a slow-release bolus that remains in the animal’s stomach, gradually delivering a methane-inhibiting compound called bromoform. This method enables consistent emissions reductions in grazing systems.
Initial animal trials indicate that this first-generation product can achieve a remarkable 75% reduction in methane emissions for over three months with just a single dose. The team is optimistic about extending this duration to six months in the future.
Future Prospects and Regulatory Approvals
The company anticipates initial regulatory approval in New Zealand by early 2026. To support this growth, Ruminant BioTech has commissioned a pilot plant capable of producing one million doses annually, focusing on the Australian and New Zealand markets. The firm has set an ambitious goal to treat 100 million cows globally with its technology by 2035, following a successful $17 million NZD ($9.5 million) Series A funding round last year.
Tackling the Methane Challenge
Methane is a potent greenhouse gas primarily released through livestock burps and manure. Various strategies are being explored to mitigate this issue, including the use of feed additives like red seaweed and 3-NOP, alongside innovative breeding programs and genetic editing of rumen microbes.
Tom Breen, CEO of Ruminant BioTech, emphasizes that there is no universal solution to this complex problem. He notes that while feed additives are effective in intensive farming systems, pasture-raised cattle require a more sustainable, long-term approach.
“We believe our cost structure is more favorable than many current feed additive models. As we scale and innovate, costs will continue to decrease significantly,” Breen stated.
Confidence in Carbon Markets
The question remains: who will ultimately bear the cost of livestock methane reduction solutions? Breen is optimistic that carbon insetting and offsetting will provide sufficient incentives for farmers, even in an environment where some companies are scaling back on sustainability initiatives.
He highlights the global agrifood sector’s increasing commitment to reducing emissions, with over 550 companies already making ambitious climate pledges. Breen cites Brazilian meat giant Marfrig as an example of a company reinforcing its methane emission targets, signaling a demand for effective solutions.
“The scale of carbon markets supports our confidence. Over the past two decades, these markets have evolved into a trillion-dollar industry, with 25% of global emissions now being accounted for. As new markets and mechanisms are implemented, the demand for emissions reduction will only grow,” he added.
The Power of the Bolus
The bolus, a solid capsule, serves as an efficient delivery mechanism for various substances, including minerals and probiotics, directly into the cow’s rumen. Administered orally using a specialized bolus gun, it ensures safe and effective swallowing.
Breen explains that the founders of Ruminant BioTech recognized the potential of Asparagopsis, a type of red seaweed known for its methane-reducing properties, but realized it wouldn’t be practical for New Zealand’s pasture-raised system. They ingeniously extracted the active ingredient, bromoform, and combined it with their expertise in bolus technology to create a solution with extended duration and high methane mitigation potential.
Conclusion
Ruminant BioTech is poised to revolutionize the cattle industry with its innovative methane reduction technology. By establishing a foothold in Canada and leveraging its unique slow-release bolus, the company is on track to become a key player in the global fight against climate change. As the demand for sustainable agricultural practices grows, Ruminant BioTech’s approach could very well set the standard for the future of livestock management.
- Ruminant BioTech launches a $5.6 million research program in Canada.
- The company aims to validate its methane reduction technology for beef cattle.
- Initial trials show a 75% reduction in methane emissions with a single dose.
- The firm plans to treat 100 million cows globally by 2035.
- Ruminant BioTech seeks to leverage carbon markets for sustainability incentives.
Read more → agfundernews.com